InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Dickinson Jonathan Elliott, Chairman & CEO. Director active across 1 companies, notably INCYTE CORP. Aggregated, 10 filings have been recorded. Total volume traded: €981k. The latest transaction was filed on 31 January 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations10 total
€490,6147,375 shares@ €66.52390.0026% mcap48.0% of flow
Common Stock
SEC:0001209191-22-006373:0·
€490,6147,375 shares@ €66.52390.0026% mcap96.0% of flow
Common Stock
SEC:0001209191-22-006373·
€5,18178 shares@ €66.42880.0000% mcap1.0% of flow
Common Stock
SEC:0001209191-22-005051·
€5,18178 shares@ €66.42880.0000% mcap0.5% of flow
Common Stock
SEC:0001209191-22-005051:0·
€6,639101 shares@ €65.73730.0000% mcap0.6% of flow
Common Stock
SEC:0001209191-22-004036:0·
€6,639101 shares@ €65.73730.0000% mcap1.3% of flow
Common Stock
SEC:0001209191-22-004036·
€8,641136 shares@ €63.53610.0000% mcap1.7% of flow
Common Stock
SEC:0001209191-22-002190·
€8,641136 shares@ €63.53610.0000% mcap0.8% of flow
Common Stock
SEC:0001209191-22-002190:0·
03,615 shares0
Common Stock
SEC:0001209191-22-001637·
03,615 shares0
Common Stock
SEC:0001209191-22-001637:0·
10 of 10 declarations
About Dickinson Jonathan Elliott
Jonathan Elliott Dickinson is the Chairman and CEO of Incyte Corp. In this role, he leads the company in its strategic and operational initiatives, thereby strengthening its position in the biopharmaceutical market. His leadership is essential in guiding Incyte toward new growth opportunities. Jonathan Elliott Dickinson has extensive experience in the sector, enabling him to make informed decisions for the company's future.
